MBX
MBX Biosciences, Inc.
NASDAQ · Healthcare · Biotechnology · US
$62.91
−1.53%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-25.5%
Return on equity
-23.9%
Return on assets
-28.6%
Return on invested capital
0.00x
Asset turnover
-$82.7M
Cash from operations
$8.69
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026